Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nightstar Therapeutics PLC

www.nightstarx.co.uk

Latest From Nightstar Therapeutics PLC

Deal Watch: Oncternal Goes Public Via Reverse Merger With GTx

All-stock transaction combines privately held Oncternal with GTx, which had been considering its strategic alternatives. Biogen acquires gene therapy biotech Nightstar, MaxCyte and Kite expand their CAR-T partnership.

Deals Business Strategies

How Roche Won The Bidding Battle For Spark

An SEC filing offers a fascinating insight into how Spark CEO Jeff Marrazzo and his board managed to play off a number of suitors against each other and get Roche to up its bid from $70 per share to $114.50.

M & A Strategy

IPO Update: Gottlieb’s Resignation Pulls Down Five Of Eight Newly Public Biopharmas

There have been eight US biopharma IPOs in 2019, but only three are trading above their launch price – a big change from just three days ago.

Financing Business Strategies

Gene Therapy Investment At All Time High, Commercialization Challenges Noted

Investor appetite for cell and gene therapy companies has skyrocketed during the past year. However, storm clouds may gather as manufacturing and reimbursement challenges remain.

Regenerative Medicine Financing
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
  • Therapeutic Areas
  • Ophthalmic
  • Alias(es)
  • Nightstar Therapeutics Ltd.
  • NightstaRx Ltd.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Nightstar Therapeutics PLC
  • Senior Management
  • David Fellows, CEO
    Senthil Sundaram, CFO
    Gregory Robinson, PhD, CSO
    Tuyen Ong, MD, Chief Dev. Officer
  • Contact Info
  • Nightstar Therapeutics PLC
    Phone: (0)20 7611 2077
    9-10 Midford Pl.
    London, W1T 5BJ
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register